BioProcess International is part of the Informa Connect Division of Informa PLC

Informa PLC|ABOUT US|INVESTOR RELATIONS|TALENT

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

BPI Events About Subscribe Contribute

Upstream

Recent in Upstream

See all

Comprehensive risk assessment framework

Biochemicals/Raw Materials

Buffer and Solution Mixing-Time Validation: A Risk-Assessment Framework for Analysts Using Matrix and Bracketing Approaches Buffer and Solution Mixing-Time Validation: A Risk-Assessment Framework for Analysts Using Matrix and Bracketing Approaches

byNaveenganesh Muralidharan, Leya S. Roseand 6 more

Jan 29, 2025

thumbnail

Bioreactors

Lessons in Bioreactor Scale-Up, Part 5: Theoretical and Empirical Correlations for Predicting the Mass-Transfer Coefficient in Stirred-Tank Bioreactors Lessons in Bioreactor Scale-Up, Part 5: Theoretical and Empirical Correlations for Predicting the Mass-Transfer Coefficient in Stirred-Tank Bioreactors

byMuhammad Arshad Chaudhry

Jan 29, 2025

Downstream

Recent in Downstream

See all

Bio-Rad BPI Ask the Expert Webcast

Sponsored Content

Demonstrating a Modular Selectivity With a Weak AEX-HIC Resin for Achieving High mAb Purity and Recovery in a Downstream Process Demonstrating a Modular Selectivity With a Weak AEX-HIC Resin for Achieving High mAb Purity and Recovery in a Downstream Process

byBPI Contributor

Jan 28, 2025

15 Min View

Nagase special report

Sponsored Content

Advanced Saccharide Solutions in Biopharmaceutical Development: Paving the Way for Product Stability and Environmental Sustainability Advanced Saccharide Solutions in Biopharmaceutical Development: Paving the Way for Product Stability and Environmental Sustainability

byYosuke Shimojo, Toshio Ariyasuand 1 more

Dec 9, 2024

Manufacturing

Recent in Manufacturing

See all

elucidation

Careers & Training

A Key Talent and Expertise Required for Continuous Versus Batch Biomanufacturing A Key Talent and Expertise Required for Continuous Versus Batch Biomanufacturing

byJason Beckwith, William Nixonand 2 more

Jan 29, 2025

Comprehensive risk assessment framework

Biochemicals/Raw Materials

byNaveenganesh Muralidharan, Leya S. Roseand 6 more

Jan 29, 2025

Analytical

Recent in Analytical

See all

Avid Bioservices BPI special report

Sponsored Content

Optimizing Production and Accelerating the Timeline from Cell Line Development to CGMP Production Optimizing Production and Accelerating the Timeline from Cell Line Development to CGMP Production

byPramthesh Patel

Feb 5, 2025

Example upstream cell-culture process

Contract Services

Technology Transfer for Outsourced Programs: Highlighting Upstream Considerations Technology Transfer for Outsourced Programs: Highlighting Upstream Considerations

byNikki Nogal

Jan 29, 2025

Business

Recent in Business

See all

Insider Outsourcing eBook

Sponsored Content

eBook: Outsourcing — CDMO Dependence, CRO Developments eBook: Outsourcing — CDMO Dependence, CRO Developments

byDan Stanton, Gareth Macdonald

Feb 18, 2025

elucidation

Careers & Training

A Key Talent and Expertise Required for Continuous Versus Batch Biomanufacturing A Key Talent and Expertise Required for Continuous Versus Batch Biomanufacturing

byJason Beckwith, William Nixonand 2 more

Jan 29, 2025

Therapeutic Modalities

Recent in Therapeutic Modalities

See all

scientists on greenhouse

Emerging Therapeutics

Recombinant Human Collagen: Plant-Based Production Addresses Growing Demand for a Vegan Option Recombinant Human Collagen: Plant-Based Production Addresses Growing Demand for a Vegan Option

byBarry Gunn

Jan 29, 2025

Antibody-Drug Conjugate eBook

Sponsored Content

eBook: Antibody-Drug Conjugates — A Technology Update eBook: Antibody-Drug Conjugates — A Technology Update

byShreeyashi Ojha, Josh Abbottand 4 more

Jan 24, 2025

BioProcess Insider

Recent in BioProcess Insider

See all

Hands holding an origami bluebird

Deal-Making

Carlyle and SK Capital to acquire bluebird bio Carlyle and SK Capital to acquire bluebird bio

byJosh Abbott

Feb 21, 2025

2 Min Read

An Irish flag waves in front of a cloudy sky

Facilities & Capacity

Irish ayes: An overview of recent biologics deals Irish ayes: An overview of recent biologics deals

byGareth Macdonald

Feb 19, 2025

4 Min Read

Business

November 2013 Issue Author InsightsNovember 2013 Issue Author Insights

BPI Contributor

November 1, 2013

1 Min Read

Subscribe to receive our monthly print or digital publication

Join our 70,000+ readers. And yes, it's completely free.

Webinars

Ask the Expert webcasts

ATE Webcasts

Event Report

Exclusive eBook

eBook: Biotech Week Boston Post-event Report

Read Now

Insider News

Carlyle and SK Capital to acquire bluebird bio
Feb 21, 2025
|
2 Min Read
Irish ayes: An overview of recent biologics deals
Feb 19, 2025
|
4 Min Read
Celonic to produce mAb for LINDIS Biotech
Feb 19, 2025
|
1 Min Read
Sartorius annual report predicts 'demand recovery and growth' for 2025
Feb 19, 2025
|
2 Min Read

See all

Mar 18 - Mar 21, 2025

SLASH TIME FROM BENCH TO BEDSIDE: Cutting-edge biomanufacturing for mAbs, vaccines, and advanced therapies. Bright ideas, bold science, and big innovations—delivering efficiency, precision, and quality through every phase of bioprocessing.

Learn More